| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 03/03/2011 | WO2011025940A1 Raf inhibitor compounds and methods of use thereof |
| 03/03/2011 | WO2011025938A2 Raf inhibitor compounds and methods of use thereof |
| 03/03/2011 | WO2011025932A2 Preparation of sitagliptin and salts thereof |
| 03/03/2011 | WO2011025505A1 Pteridines and their use as agrochemicals |
| 03/03/2011 | WO2011025501A1 Naphthalocyanine dye and ink containing the same |
| 03/03/2011 | WO2011024871A1 Fused heterocyclic ring derivative and use thereof |
| 03/03/2011 | WO2011024869A1 Fused heterocyclic ring derivative and use thereof |
| 03/03/2011 | WO2011023795A1 (thio)morpholine derivatives as s1p modulators |
| 03/03/2011 | WO2011023783A2 Method for preparing silica particles containing a phthalocyanine derivative, said particles, and uses thereof |
| 03/03/2011 | WO2011023693A1 Methylpyrrolopyrimidinecarboxamides |
| 03/03/2011 | WO2011023667A1 Carbocyclic glyt1 receptor antagonists |
| 03/03/2011 | WO2010123919A3 Piperidine inhibitors of janus kinase 3 |
| 03/03/2011 | WO2010036998A3 Indole and indoline derivatives and methods of use thereof |
| 03/03/2011 | US20110054170 Six-membered N-Heterocyclic Carbene-based catalysts for asymmetric reactions |
| 03/03/2011 | US20110053945 Salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihy-dro-5h-pyrrolo[3,4-b]pyrazine |
| 03/03/2011 | US20110053943 CARBAMATE AND UREA INHIBITORS OF 11ß-HYDROXYSTEROID DEHYDROGENASE 1 |
| 03/03/2011 | US20110053937 Inhibitors of the Interaction Between MDM2 and P53 |
| 03/03/2011 | US20110053936 substituted spiro[cycloalkyl-1,3'-indol]-2'(1'h)-one derivatives and their use as p38 mitogen-activated kinase inhibitors |
| 03/03/2011 | US20110053930 Inhibitors of the bmp signaling pathway |
| 03/03/2011 | US20110053929 Imidazo-, pyrazolopyrazines and imidazotriazines and their use |
| 03/03/2011 | US20110053920 Substituted bicyclic pyrimidines |
| 03/03/2011 | US20110053916 Pyrimidine compounds as tuberculosis inhibitors |
| 03/03/2011 | US20110053915 HETEROCYCLIC INHIBITORS OF AN Hh-SIGNAL CASCADE, MEDICINAL COMPOSITIONS BASED THEREON AND METHODS FOR TREATING DISEASES CAUSED BY THE ABERRANT ACTIVITY OF AN Hh-SIGNAL SYSTEM |
| 03/03/2011 | US20110053911 Tricyclic derivatives as inhibitors of poly(adp-ribose) polymerase (parp) |
| 03/03/2011 | US20110053907 Substituted pyrimidines and triazines and their use in cancer therapy |
| 03/03/2011 | US20110053904 Carbocyclic glyt1 receptor antagonists |
| 03/03/2011 | US20110053892 Imidazo[4,5-d]Pyridazine Compounds For Treating Viral Infections |
| 03/03/2011 | US20110053883 Agent that modulates physiological condition of pests, involved in insect c-jun amino-terminal kinase activity |
| 03/03/2011 | US20110053282 Methods and Kits Using Extended Rhodamine Dyes |
| 03/03/2011 | US20110053038 Co(ii)tetramethoxyphenylporphyrin additive to pfsa pems for improved fuel cell durability |
| 03/03/2011 | US20110052562 Benzimidazoles and analogs as rho kinase inhibitors |
| 03/03/2011 | US20110052534 Imidazopyridazine Compounds for Treating Viral Infections |
| 03/03/2011 | US20110052528 Neuroprotective macrocyclic compounds and methods for their use |
| 03/03/2011 | US20110049488 Heterocyclic compound and organic light-emitting device including the same |
| 03/03/2011 | US20110049485 Organic light-emitting device |
| 03/03/2011 | CA2772169A1 (thio)morpholine derivatives as s1p modulators |
| 03/03/2011 | CA2772074A1 Raf inhibitor compounds and methods of use thereof |
| 03/03/2011 | CA2772071A1 Raf inhibitor compounds and methods of use thereof |
| 03/03/2011 | CA2771938A1 Methylpyrrolopyrimidinecarboxamides |
| 03/03/2011 | CA2771895A1 Raf inhibitor compounds and methods of use thereof |
| 03/03/2011 | CA2771893A1 Raf inhibitor compounds and methods of use thereof |
| 03/03/2011 | CA2769922A1 Pteridines and their use as agrochemicals |
| 03/03/2011 | CA2767901A1 Carbocyclic glyt1 receptor antagonists |
| 03/02/2011 | EP2289894A2 Pyrrolo-triazine compounds useful as kinase inhibitors |
| 03/02/2011 | EP2289892A1 Maleimide derivatives, pharmaceutical compositions amd methods for treatment of cancer |
| 03/02/2011 | EP2289877A1 Organic light emitting device containing polycyclic heteroaryl compounds |
| 03/02/2011 | EP2288613A1 Phenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as bace-1 inhibitors, compositions, and their use |
| 03/02/2011 | EP2288612A1 Gabaa receptor modulators |
| 03/02/2011 | EP2288611A1 Aurora kinase modulators and method of use |
| 03/02/2011 | EP2288610A1 Azetidine and cyclobutane derivatives as jak inhibitors |
| 03/02/2011 | EP2288351A2 Novel pyrrolidone derivatives for use as metap-2 inhibitors |
| 03/02/2011 | EP1704148B1 Novel fused pyrrolocarbazoles |
| 03/02/2011 | CN1918158B Compounds and compositions as protein kinase inhibitors |
| 03/02/2011 | CN101983200A Compound capable of absorbing infrared ray, and microparticles comprising the compound |
| 03/02/2011 | CN101983199A 1-heterocyclyl-1,5-dihydro-pyrazolo[3,4-d] pyrimidin-4-one derivatives and their use as pde9a modulators |
| 03/02/2011 | CN101983191A Oxim derivatives as hsp90 inhibitors |
| 03/02/2011 | CN101983189A Method for producing isoindole and isoindole produced by the method for producing isoindole |
| 03/02/2011 | CN101982461A Diacid monomer with amino acid chiral source and preparation method thereof |
| 03/02/2011 | CN101982456A Production method of environmental-friendly chloroacetic acid-process glycine |
| 03/02/2011 | CN101305011B Pyridine derivatives and their use in the treatment of psychotic disorders |
| 03/01/2011 | US7897771 Fused heterocyclic compounds |
| 03/01/2011 | US7897762 Kinase inhibitors useful for the treatment of proliferative diseases |
| 03/01/2011 | US7897639 Amine group that, upon hydrolysis, becomes a component of a pharmacologically active agent for treatment of nervous system disordres |
| 03/01/2011 | US7897607 Cyclic compounds |
| 03/01/2011 | US7897595 Pyridoazepine derivatives |
| 03/01/2011 | US7897590 Methods to mobilize progenitor/stem cells |
| 02/24/2011 | WO2011001113A3 Novel 1,2,3,4-tetrahydro-pyrimido(1,2-a)pyrimidin-6-one derivatives, preparation thereof, and pharmaceutical use thereof |
| 02/24/2011 | WO2010114267A3 Organic electronic device, compounds for same, and terminal |
| 02/24/2011 | WO2010077663A3 Substituted tetracyclic 1h-indeno (1,2-b) pyridine-2 (5h)-one analogs thereof and uses thereof |
| 02/24/2011 | WO2010028780A3 Preparation and uses of guanidinium-modified porphyrins and phthalocyanines |
| 02/24/2011 | US20110046368 Ligands of 5-ht6 receptors, a pharmaceutical composition, method for the production and use thereof |
| 02/24/2011 | US20110046366 Liquid porphyrin derivative, and method for producing the same |
| 02/24/2011 | US20110046189 Heteroaryl-substituted bicyclic smac mimetics and the uses thereof |
| 02/24/2011 | US20110046167 Acyclic amine inhibitors of 5-methytioadenosine phosphorylase and nucleosidase |
| 02/24/2011 | US20110046165 Certain chemical entitles, compositions and methods |
| 02/24/2011 | US20110046144 Imidazopyrazinol derivatives for the treatment of cancers |
| 02/24/2011 | US20110046132 Benzoimidazoles as prolyl hydroxylase inhibitors |
| 02/24/2011 | US20110046127 Imidazopyridazines for Use as Protein Kinase Inhibitors |
| 02/24/2011 | US20110046118 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical use |
| 02/24/2011 | US20110046111 Quinazoline linked pyrrolo[2,1-c][1, 4]benzodiazepine hybrids as potential anticancer agents and process for the preparation thereof |
| 02/24/2011 | US20110046107 Sulfonyl-substituted carbapenem compounds |
| 02/24/2011 | US20110046093 Pyrimidine derivatives as protein kinase inhibitors |
| 02/24/2011 | US20110046000 Methods to increase the photostability of dyes |
| 02/24/2011 | US20110045585 Kit for fluorometric analysis |
| 02/24/2011 | US20110044943 Anti-Viral Compounds, Compositions, And Methods Of Use |
| 02/24/2011 | US20110044902 Modulation of the Immune Response |
| 02/24/2011 | US20110044898 Translocator protein ligands |
| 02/23/2011 | EP2287167A1 Polycyclic agents for the treatment of respiratory syncytial virus infections |
| 02/23/2011 | EP2287166A2 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 02/23/2011 | EP2287165A2 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 02/23/2011 | EP2286812A1 Solubilized topoisomerase poisons |
| 02/23/2011 | EP2285811A1 3-(3-pyrimidin-2-yl-benzyl)-ý1,2,4¨triazoloý4,3-b¨pyridazine derivatives as met kinase inhibitors |
| 02/23/2011 | EP2285810A1 Selective ligands for the neuronal nicotinic receptors and uses thereof |
| 02/23/2011 | EP2285809A1 1,4-diaryl-pyrimidopyridazine-2,5-diones and their use |
| 02/23/2011 | EP2285808A1 Spiro-indole derivatives for the treatment of parasitic diseases |
| 02/23/2011 | EP1812388B1 Sulfonamide peri-substituted bicyclics for occlusive artery disease |
| 02/23/2011 | EP1682520B1 Amide derivatives |
| 02/23/2011 | EP1654263B2 Phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor |
| 02/23/2011 | CN1946725B Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 02/23/2011 | CN101981037A Pyrazolopyrimidine PI3K inhibitor compounds and methods of use |